Bronchoscopy safety in interstitial lung disease
Part of Lungs & breathing clinical trials.
This study checks how safe bronchoscopy is for people with interstitial lung disease (ILD), a condition that scars the lungs. It aims to provide better information to help doctors and patients decide if this procedure is right for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with or are suspected of having interstitial lung disease (ILD).
- Your doctor has recommended a bronchoscopy as part of your regular care.
- You are willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a lung biopsy method that uses ultrasound to guide a needle through the chest wall to take a small tissue sample. The goal is to see if it's safe for people with diffuse interstitial lung disease, which may help doctors get a more accurate diagnosis.
This study compares a robotic-assisted bronchoscope to a conventional one for performing a lung biopsy (cryobiopsy) in people with interstitial lung disease. The goal is to see which method is better at getting enough tissue for a diagnosis.
This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.
This study follows patients with chronic lung scarring (fibrosing interstitial lung disease) who are in the intensive care unit for severe breathing failure. It aims to better understand their condition and care, which may help improve future treatments.
This study uses a fluid sample taken from your lungs (called bronchoalveolar lavage) to understand the specific types of inflammation in different forms of interstitial lung disease. This may help doctors tailor better treatments for you in the future.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
Hear when a new Bronchoscopy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.